{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:25:36Z","timestamp":1787221536549,"version":"build-2736575974"},"reference-count":61,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Background: Hantavirus pulmonary syndrome (HPS), also designated hantavirus cardiopulmonary syndrome, is caused by New World hantaviruses, principally Sin Nombre virus in North America and Andes virus in South America. The syndrome is characterized by rapidly progressive noncardiogenic pulmonary edema and myocardial depression, with case fatality rates of 25% to 40%. A 2026 outbreak aboard an expedition cruise ship in the South Atlantic, comprising 13 cases and three deaths, confirmed that Andes virus can be transmitted between humans in a confined setting remote from the rodent reservoir. Methods: Virological, pathophysiological, clinical, and therapeutic aspects of HPS were reviewed, with particular emphasis on cardiopulmonary mechanisms. Sources were identified through PubMed, Scopus, and Google Scholar, with priority given to original research articles, clinical series, and controlled trials published through 2025. Literature published in English and Spanish was included. Results: Pathogenic hantaviruses enter endothelial cells and platelets via \u03b1v\u03b23 integrins, disrupting the VEGF-VEGFR2 signaling axis and rendering endothelial cells hypersensitive to physiological VEGF concentrations. Expansion of CD8+ T cells and activated macrophages releases TNF-alpha, IFN-gamma, and nitric oxide, amplifying microvascular permeability and contributing to myocardial depression. Autopsy studies demonstrate direct hantaviral myocarditis with viral antigen in cardiac endothelium and interstitial macrophages. Transpulmonary thermodilution confirms simultaneous hypovolemia, reduced global ejection fraction, and elevated extravascular lung water. Because the incubation period is long and the cardiopulmonary phase is substantially immune-mediated, seroconversion precedes rather than follows clinical deterioration, which preserves the diagnostic utility of IgM serology in a disease that can kill within 48 h. VA-ECMO initiated at the first signs of cardiopulmonary decompensation has reported survival rates approaching 80% in selected experienced centers. No antiviral has demonstrated efficacy in controlled trials during the cardiopulmonary phase, and no licensed vaccine exists. Conclusions: HPS produces a mixed shock state through increased microvascular permeability, T cell-mediated immunopathology, and direct myocarditis. Management follows a stepwise algorithm: suspected HPS triggers immediate complete blood count with peripheral blood smear and concurrent hantavirus IgM serology and RT-PCR, followed by ICU admission, conservative fluid resuscitation guided by transpulmonary thermodilution, and early contact with an ECMO-capable center at the first sign of rising lactate, falling cardiac index, refractory shock, arrhythmia, or rapid oxygenation failure.<\/jats:p>","DOI":"10.3390\/v18080915","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:48:31Z","timestamp":1787219311000},"page":"915","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiopulmonary Failure in Hantavirus Disease: Mechanisms, Recognition, and ECMO-Based Management"],"prefix":"10.3390","volume":"18","author":[{"given":"Deng Siang","family":"Lee","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Health Sciences, University of Barcelona, 08007 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aboubakr","family":"Hasan","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Stanford University, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3201\/eid1707.101306","article-title":"Hantavirus pulmonary syndrome, United States, 1993\u20132009","volume":"17","author":"MacNeil","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJM199404073301401","article-title":"Hantavirus pulmonary syndrome: Aclinical description of 17 patients with a newly recognized disease","volume":"330","author":"Duchin","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1128\/CMR.00062-09","article-title":"A global perspective on hantavirus ecology, epidemiology, and disease","volume":"23","author":"Jonsson","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/viro.1997.8976","article-title":"Hantavirus pulmonary syndrome outbreak in Argentina: Molecular evidence for person-to-person transmission of Andes virus","volume":"241","author":"Padula","year":"1998","journal-title":"Virology"},{"key":"ref_5","unstructured":"Centers for Disease Control and Prevention (2026, July 10). Reported Cases of Hantavirus Disease, Available online: https:\/\/www.cdc.gov\/hantavirus\/data-research\/cases\/index.html."},{"key":"ref_6","unstructured":"Pan American Health Organization (2026, July 10). Epidemiological Alert: Hantavirus Pulmonary Syndrome in the Americas Region, 19 December 2025. Available online: https:\/\/www.paho.org\/en\/documents\/epidemiological-alert-hantavirus-pulmonary-syndrome-americas-region-19-december-2025."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.virusres.2014.01.015","article-title":"Hantaviruses and cardiopulmonary syndrome in South America","volume":"187","author":"Figueiredo","year":"2014","journal-title":"Virus Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Goodfellow, S.M., Nofchissey, R.A., Ye, C., Banther-McConnell, J.K., Suriyamongkol, T., Cook, J.A., Dunnum, J.L., Mali, I., and Bradfute, S.B. (2025). A human pathogenic hantavirus circulates and is shed in taxonomically diverse rodent reservoirs. PLoS Pathog., 21.","DOI":"10.1371\/journal.ppat.1012849"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/jmv.20948","article-title":"Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter","volume":"79","author":"Kaukinen","year":"2007","journal-title":"J. Med. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Andes Virus Outbreak Working Group (2026). Andes hantavirus outbreak on a cruise ship, 2026. N. Engl. J. Med., 394, 2477\u20132479.","DOI":"10.1056\/NEJMc2606496"},{"key":"ref_11","unstructured":"World Health Organization (2026, July 10). Disease Outbreak News. Hantavirus Outbreak Linked to Cruise Ship Travel, Multi-Locations. 2 July 2026. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2026-DON611."},{"key":"ref_12","unstructured":"BRIEF TA (2026). Hantavirus-Associated Cluster of Illness on a Cruise Ship: ECDC Assessment and Recommendations. 6 May 2026."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7074","DOI":"10.1073\/pnas.95.12.7074","article-title":"\u03b23 integrins mediate the cellular entry of hantaviruses that cause respiratory failure","volume":"95","author":"Gavrilovskaya","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1128\/JVI.73.5.3951-3959.1999","article-title":"Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by \u03b23 integrins","volume":"73","author":"Gavrilovskaya","year":"1999","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41586-018-0702-1","article-title":"Protocadherin-1 is essential for cell entry by New World hantaviruses","volume":"563","author":"Jangra","year":"2018","journal-title":"Nature"},{"key":"ref_16","first-page":"552","article-title":"Hantavirus pulmonary syndrome: Pathogenesis of an emerging infectious disease","volume":"146","author":"Zaki","year":"1995","journal-title":"Am. J. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0046-8177(95)90123-X","article-title":"Hantavirus pulmonary syndrome in the United States: A pathological description of a disease caused by a new agent","volume":"26","author":"Nolte","year":"1995","journal-title":"Hum. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1128\/JVI.02397-07","article-title":"Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability","volume":"82","author":"Gavrilovskaya","year":"2008","journal-title":"J. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"L\u00f3pez, R., P\u00e9rez-Araos, R., Salazar, \u00c1., Ulloa, A.L., Vial, C., Vial, P.A., and Graf, J. (2019). Hemodynamic and pulmonary permeability characterization of hantavirus cardiopulmonary syndrome by transpulmonary thermodilution. Viruses, 11.","DOI":"10.20944\/preprints201908.0053.v1"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Meza-Fuentes, G., L\u00f3pez, R., Vial, C., Cortes, L.J., Retamal, M.A., Delgado, I., and Vial, P. (2023). Assessing pulmonary epithelial damage in hantavirus cardiopulmonary syndrome: Challenging the predominant role of vascular endothelium through sRAGE as a potential biomarker. Viruses, 15.","DOI":"10.3390\/v15101995"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1099\/vir.0.032367-0","article-title":"RNA helicase retinoic acid-inducible gene I as a sensor of Hantaan virus replication","volume":"92","author":"Lee","year":"2011","journal-title":"J. Gen. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.4049\/jimmunol.0802893","article-title":"Hantaan virus triggers TLR3-dependent innate immune responses","volume":"182","author":"Handke","year":"2009","journal-title":"J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Habjan, M., Andersson, I., Klingstr\u00f6m, J., Sch\u00fcmann, M., Martin, A., Zimmermann, P., Wagner, V., Pichlmair, A., Schneider, U., and M\u00fchlberger, E. (2008). Processing of genome 5\u2032 termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0002032"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9676","DOI":"10.1128\/JVI.00508-06","article-title":"The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I-and TBK-1-directed interferon responses","volume":"80","author":"Alff","year":"2006","journal-title":"J. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/imm.13322","article-title":"Immune response during hantavirus diseases: Implications for immunotherapies and vaccine design","volume":"163","author":"Saavedra","year":"2021","journal-title":"Immunology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00003246-199602000-00012","article-title":"Cardiopulmonary manifestations of hantavirus pulmonary syndrome","volume":"24","author":"Hallin","year":"1996","journal-title":"Crit. Care Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Simons, P., Guo, Y., Bondu, V., Tigert, S.L., Harkins, M., Goodfellow, S., Tompkins, C., Chabot-Richards, D., Yang, X.O., and Bosc, L.G. (2021). Longitudinal assessment of cytokine expression and plasminogen activation in hantavirus cardiopulmonary syndrome reveals immune regulatory dysfunction in end-stage disease. Viruses, 13.","DOI":"10.3390\/v13081597"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.imlet.2007.08.003","article-title":"Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: Do CD8+ T cells trigger capillary leakage in viral hemorrhagic fevers?","volume":"113","author":"Terajima","year":"2007","journal-title":"Immunol. Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1006\/viro.1997.8827","article-title":"Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness","volume":"238","author":"Ennis","year":"1997","journal-title":"Virology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41467-024-44687-4","article-title":"Disparate macrophage responses are linked to infection outcome of Hantan virus in humans or rodents","volume":"15","author":"Ma","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Bondu, V., Bitting, C., Poland, V.L., Hanson, J.A., Harkins, M.S., Lathrop, S., Nolte, K.B., Lawrence, D.A., and Buranda, T. (2018). Upregulation of P2Y2R, active uPA, and PAI-1 are essential components of hantavirus cardiopulmonary syndrome. Front. Cell. Infect. Microbiol., 8.","DOI":"10.3389\/fcimb.2018.00169"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1086\/315657","article-title":"Humoral immune responses in the hantavirus cardiopulmonary syndrome","volume":"182","author":"Bharadwaj","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1086\/513874","article-title":"Hantavirus infection induces a typical myocarditis that may be responsible for myocardial depression and shock in hantavirus pulmonary syndrome","volume":"195","author":"Saggioro","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_34","unstructured":"Centers for Disease Control and Prevention (2026, July 10). Clinician Brief: Hantavirus Pulmonary Syndrome (HPS), Available online: https:\/\/www.cdc.gov\/hantavirus\/hcp\/clinical-overview\/hps.html."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"714","DOI":"10.4269\/ajtmh.2000.62.714","article-title":"The incubation period of hantavirus pulmonary syndrome","volume":"62","author":"Young","year":"2000","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3201\/eid0404.980425","article-title":"An outbreak of hantavirus pulmonary syndrome, Chile, 1997","volume":"4","author":"Toro","year":"1998","journal-title":"Emerg. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1309\/CNWF-DC72-QYMR-M8DA","article-title":"Rapid presumptive diagnosis of hantavirus cardiopulmonary syndrome by peripheral blood smear review","volume":"116","author":"Koster","year":"2001","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1309\/AJCPNFVWG46NUHED","article-title":"Successful triage of suspected hantavirus cardiopulmonary syndrome by peripheral blood smear review","volume":"142","author":"Dvorscak","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1128\/jcm.35.3.600-608.1997","article-title":"Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis","volume":"35","author":"Hjelle","year":"1997","journal-title":"J. Clin. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"154867","DOI":"10.1016\/j.jcrc.2024.154867","article-title":"Critical care management of hantavirus cardiopulmonary syndrome. A narrative review","volume":"84","author":"Pavez","year":"2024","journal-title":"J. Crit. Care"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1128\/jvi.68.2.592-596.1994","article-title":"A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: Evolutionary relationships to known hantaviruses","volume":"68","author":"Hjelle","year":"1994","journal-title":"J. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3201\/eid1205.051487","article-title":"Hantavirus in African wood mouse, Guinea","volume":"12","author":"Klempa","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0168-1702(93)90101-R","article-title":"Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome","volume":"30","author":"Feldmann","year":"1993","journal-title":"Virus Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1002\/jmv.26930","article-title":"Targeted high volume hemofiltration could avoid extracorporeal membrane oxygenation in some patients with severe hantavirus cardiopulmonary syndrome","volume":"93","author":"Salazar","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5935\/0103-507X.20160032","article-title":"Hantavirus cardiopulmonary syndrome successfully treated with high-volume hemofiltration","volume":"28","author":"Bugedo","year":"2016","journal-title":"Rev. Bras. Ter. Intensiv."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"(2000). Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury the acute respiratory distress syndrome. N. Engl. J. Med., 342, 1301\u20131308.","DOI":"10.1056\/NEJM200005043421801"},{"key":"ref_47","first-page":"415851","article-title":"Prone position ventilation used during a transfer as a bridge to ECMO therapy in hantavirus-induced severe cardiopulmonary syndrome","volume":"2013","author":"Cornejo","year":"2013","journal-title":"Case Rep. Crit. Care"},{"key":"ref_48","first-page":"122","article-title":"Impact of early ECMO support on survival of patients with hantavirus cardiopulmonary syndrome in Chile","volume":"60","author":"Hernandez","year":"2022","journal-title":"Eur. Respir. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1086\/425007","article-title":"Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America","volume":"39","author":"Mertz","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/135965359900400404","article-title":"Intravenous ribavirin for hantavirus pulmonary syndrome: Safety and tolerance during 1 year of open-label experience","volume":"4","author":"Chapman","year":"1999","journal-title":"Antivir. Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1128\/AAC.00886-13","article-title":"Antiviral efficacy of favipiravir against two prominent etiological agents of hantavirus pulmonary syndrome","volume":"57","author":"Safronetz","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Mayor, J., Engler, O., and Rothenberger, S. (2021). Antiviral efficacy of ribavirin and favipiravir against Hantaan virus. Microorganisms, 9.","DOI":"10.3390\/microorganisms9061306"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/cid\/cit394","article-title":"High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in Chile: A double-blind, randomized controlled clinical trial","volume":"57","author":"Vial","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_54","first-page":"617","article-title":"Controversies on corticosteroid therapy in hantavirus cardiopulmonary syndrome","volume":"81","author":"Chediack","year":"2021","journal-title":"Medicina"},{"key":"ref_55","first-page":"1198","article-title":"Hantavirus cardiopulmonary syndrome in the intensive care unit","volume":"85","author":"Cunto","year":"2025","journal-title":"Medicina"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"eaat6420","DOI":"10.1126\/scitranslmed.aat6420","article-title":"Two recombinant human monoclonal antibodies that protect against lethal Andes hantavirus infection in vivo","volume":"10","author":"Garrido","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3851\/IMP2875","article-title":"A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome caused by Andes virus","volume":"20","author":"Vial","year":"2015","journal-title":"Antivir. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3201\/eid1201.050930","article-title":"Neutralizing antibodies in survivors of Sin Nombre and Andes hantavirus infection","volume":"12","author":"Valdivieso","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"264ra162","DOI":"10.1126\/scitranslmed.3010082","article-title":"DNA vaccine\u2013derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome","volume":"6","author":"Hooper","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s44298-026-00200-w","article-title":"Vaccines and therapeutics for Andes hantavirus","volume":"4","author":"Tscherne","year":"2026","journal-title":"npj Viruses"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/1469-0691.12553","article-title":"A Phase 1 clinical trial of H antaan virus and P uumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation","volume":"20","author":"Hooper","year":"2014","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/8\/915\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:52:46Z","timestamp":1787219566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/8\/915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":61,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["v18080915"],"URL":"https:\/\/doi.org\/10.3390\/v18080915","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]}}}